PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

Pharma Tech

Jul 4, 2026, 6:00 AM

Between two giants: Europe’s new oncology chapter takes shape in Paris

Paris is emerging as a focal point for Europe’s next phase in oncology, as science, capital and industry converge at Campus Grand Parc.

ET Pharma

Jul 4, 2026, 2:30 AM

FDA probes anesthesia-linked neurological complications in some patients of Venezuelan ancestry

The agency ‌said cases ⁠involving ⁠both adult and pediatric patients have been connected, according to ​published scientific studies, to exposure to sevoflurane, a commonly used inhaled anesthetic. ​These cases may also involve a rare mitochondrial genetic variant.

ET Pharma

Jul 4, 2026, 2:01 AM

US, West Asia drag India's pharma exports growth

Indian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to West Asia. Despite these challenges, overall exports surged by over 6%, driven by strong performance in regions like ASEAN and Latin America, and a remarkable 37% growth in vaccine exports. This indicates a resilient industry adapting to global shifts.

ET Pharma

Jul 4, 2026, 1:55 AM

Sun Pharma secures relief in 'Pantocid' trademark dispute

A bench comprising Justice Manmeet Pritam Singh Arora and Justice V Kameswar Rao, however, allowed Finecure to dispose of its existing stock with the name "Pantopacid", used for short-term treatment of acidity, within four months since it had been carrying out sales at least since 2023 and there had been no injunction till date.

Pharma Tech

Jul 3, 2026, 2:23 PM

WHO intensifies Ebola-curbing efforts through drug trial and diagnostic rollout

WHO is sponsoring a trial testing drugs for Bundibugyo virus, while adding the first Ebola diagnostic test to its emergency use list.

Pharma Tech

Jul 3, 2026, 2:20 PM

US-UK pharma trade deal paints a costly economic picture for NHS

Financial research published in the BMJ shows the trade deal could end up costing the NHS tens of billions.

News

Latest industry coverage

Google News

Jul 4, 2026, 4:06 PM

State Street Health Care ETF Tops Invesco Pharma on Cost and Size - The Motley Fool

State Street Health Care ETF Tops Invesco Pharma on Cost and Size  The Motley Fool

Google News

Jul 4, 2026, 4:05 PM

Marie Olivier Appointed Senior Vice President, Head of Global Development Operations at Bristol Myers Squibb - Oncodaily

Marie Olivier Appointed Senior Vice President, Head of Global Development Operations at Bristol Myers Squibb  Oncodaily

Google News

Jul 4, 2026, 3:55 PM

Strategic Collaboration | Sanyou Bio and Baiyunshan Xihe Join Forces to Advance Innovative Radiopharmaceuticals and Radiodiagnostics - The Manila Times

Strategic Collaboration | Sanyou Bio and Baiyunshan Xihe Join Forces to Advance Innovative Radiopharmaceuticals and Radiodiagnostics  The Manila Times

Google News

Jul 4, 2026, 3:44 PM

Biocon stock builds its case on the business, not a fresh catalyst. - Ad-hoc-news.de

Biocon stock builds its case on the business, not a fresh catalyst.  Ad-hoc-news.de

Google News

Jul 4, 2026, 3:41 PM

Anthropic targets drug discovery for neglected diseases with Claude Science initiative - Crypto Briefing

Anthropic targets drug discovery for neglected diseases with Claude Science initiative  Crypto Briefing

Google News

Jul 4, 2026, 3:21 PM

GSK Pharma outlines its role in India’s healthcare market - Ad-hoc-news.de

GSK Pharma outlines its role in India’s healthcare market  Ad-hoc-news.de

Google News

Jul 4, 2026, 2:07 PM

3SBio highlights its biotech profile as investors look at long-term growth - Ad-hoc-news.de

3SBio highlights its biotech profile as investors look at long-term growth  Ad-hoc-news.de

Google News

Jul 4, 2026, 1:48 PM

Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026? - The Motley Fool

Dyne Therapeutics vs. Recursion Pharmaceuticals: Which Development Stage Pharma Stock Is a Better Buy in 2026?  The Motley Fool

Google News

Jul 4, 2026, 1:18 PM

Sun Pharma secures relief in 'Pantocid' trademark dispute - The Economic Times

Sun Pharma secures relief in 'Pantocid' trademark dispute  The Economic Times

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer